PCV59 Cost-Effectiveness of Dabigatran Etexilate Versus Apirin Plus Clopidogrel Combination in Stroke Prevention in Atrial Fibrillation (SPAF): Russian Payer Perspective
Value in Health - United Kingdom
doi 10.1016/j.jval.2012.03.662
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2012
Authors
Publisher
Elsevier BV